Specifically, DV enhances T cell infiltration into the tumor by inducing tumor-specific, adaptive anti-tumor immunity, while PD-1 blockade rejuvenates exhausted T cells (Huang et al., 2022). The gene discussed is PDCD1; the disease is neoplasm.